Cargando…
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer’s disease (AD) being the most dominant, without efficacious drugs, and with only a few therapeutic targets identified. In this scenario, we aim to find molecular entities that modulate imidazoline I(2) receptors (I(2)...
Autores principales: | Bagán, Andrea, Rodriguez-Arévalo, Sergio, Taboada-Jara, Teresa, Griñán-Ferré, Christian, Pallàs, Mercè, Brocos-Mosquera, Iria, Callado, Luis F., Morales-García, José A., Pérez, Belén, Diaz, Caridad, Fernández-Godino, Rosario, Genilloud, Olga, Beljkas, Milan, Oljacic, Slavica, Nikolic, Katarina, Escolano, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610545/ https://www.ncbi.nlm.nih.gov/pubmed/37896141 http://dx.doi.org/10.3390/pharmaceutics15102381 |
Ejemplares similares
-
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I(2)-Imidazoline Receptor Ligand MCR5
por: Vasilopoulou, Foteini, et al.
Publicado: (2020) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023) -
Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model
por: Vasilopoulou, Foteini, et al.
Publicado: (2021) -
Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I(2) Receptor Ligand B06
por: Bagán, Andrea, et al.
Publicado: (2022) -
The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer’s Disease
por: Bellver-Sanchis, Aina, et al.
Publicado: (2021)